AI ScreeningAI ChatPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Return on equity (%)

TEVA PHARMACEUTICAL INDUSTRIES LTD【TEVA】

Market cap
$38.8B
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-24.3+264.96%
Dec 31, 2023-6.6-71.83%
Dec 31, 2022-23.6-677.26%
Dec 31, 20214.1-113.39%
Dec 31, 2020-30.5+371.45%
Dec 31, 2019-6.5-47.95%
Dec 31, 2018-12.4-79.43%
Dec 31, 2017-60.5-6093.07%
Dec 31, 20161-83.14%
Dec 31, 20156-54.93%
Dec 31, 201413.3+138.17%
Dec 31, 20135.6-35.71%
Dec 31, 20128.7-30.45%
Dec 31, 201112.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)